Skip to main content

Table 4 Patient sociodemographic and clinical characteristics

From: A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children

 

Measure

IAP

DAP

NAP

Total

  

(n = 143)

(n = 140)

(n = 139)

(n = 422)

Age

mean (SD), years

6.4 (3.1)

6.4 (3.2)

6.1 (2.8)

6.3 (3.0)

Girls

cases (%)

75 (52.5)

64 (45.7)

77 (55.4)

216 (51.2)

Respiratory comorbidity

number (%)

15 (10.5)

14 (10.0)

11 (7.9)

40 (9.5)

Respiratory infection

cases (%)

    

Rhinosinusitis

 

8 (5.6)

9 (6.4)

8 (5.8)

25 (5.9)

Pharyngitis

 

46 (32.2)

46 (32.9)

49 (35.3)

141 (33.4)

Acute bronchitis

 

14 (9.8)

12 (8.6)

13 (9.4)

39 (9.2)

Acute otitis media

 

75 (52.5)

73 (52.1)

69 (49.6)

217 (51.4)

Main specific symptomsa

mean (SD)

    

Severe (5–6)

days

2.6 (5.4)

2.4 (6)

2.6 (6.5)

3 (6)

Moderate (3–4)

 

6.9 (5.8)

7 (6.3)

6.9 (7.9)

6.95(6.7)

Complicationsb

cases

2

1

2

5

Antibioticsc

prescriptions used

146

35

17

198

Non-antibiotic medicationc

prescriptions used

173

200

231

604

Additional PC visitsc

visits, number

16

15

18

49

  1. Data are reported as frequencies and percentages except otherwise indicated
  2. DAP delayed antibiotic prescription, IAP immediate antibiotic prescription, NAP: no antibiotic prescription
  3. aFever or difficulty swallowing for pharyngitis, earache for acute otitis media, breathlessness for rhinosinusitis, and breathlessness or chest breathing noise for acute bronchitis
  4. bPerforated eardrum (n = 1); hospitalization for dehydration (n = 1); ED visits (n = 3)
  5. cData are reported in terms of frequency, as a patient may have used more than one antibiotic or non-antibiotic drugs or may have visited more than once